Press Releases

  • Fraunhofer IBMT in European Union’s Horizon 2020 IMI project EBiSC / 2022

    EBiSC2 and FAIRplus are improving FAIRness of stem cell data

    Press Release / May 17, 2022

    The FAIRplus and EBiSC2 projects are joining forces to improve how ‘FAIR’ standards (Findability, Accessibility, Interoperability and Reusability) can be applied to human induced Pluripotent Stem Cell (iPSC) line data. The joint effort will improve how iPSC line data can be made more findable, standardized and reusable for researchers.

    more info
  • Agreement signed / 2022

    New Fraunhofer Center for Sensor Intelligence in Saarland

    Press Release / February 23, 2022

    © Staatskanzlei des Saarlandes

    Saarland’s Minister President Tobias Hans and the President of the Fraunhofer-Gesellschaft, Prof. Reimund Neugebauer, signed an agreement today to establish the Fraunhofer Center for Sensor Intelligence ZSI. It will address the entire innovation chain in the pioneering field of intelligent sensor technology, bring together core areas of expertise from the regional research landscape and develop them further. The center will be housed in a new building on the campus of Saarland University as part of a joint project between the Fraunhofer Institute for Biomedical Engineering IBMT and the Fraunhofer Institute for Nondestructive Testing IZFP.

    more info
  • Fraunhofer Project Center for Stem Cell Process Engineering SPT at MEDICA 2021: Biotechnology / 2021

    Stem cells from the bioreactor

    Press Release / November 03, 2021

    © Fraunhofer IBMT, (a+b Bernd Müller)..

    With the aid of artificial stem cells, it will soon be possible to establish new treatments for previously incurable diseases such as Alzheimer’s disease. At the Fraunhofer Project Center for Stem Cell Process Engineering SPT, a process for the mass production of these so called induced pluripotent stem cells is being developed. This process involves new materials, which ensure that industrial cell production will meet high quality standards. The process will be unveiled to the public for the first time at the MEDICA trade fair in Düsseldorf, Germany, between November 15 and 18, 2021 (hall 3, stand E74).

    more info
  • Safe, patient-friendly implants for personalized therapy / 2021

    COMPAMED/MEDICA 2021: Miniaturized and networked active implants

    Press Release / November 03, 2021

    Highly integrated implant electronics with radiotelemetry and an application-specific integrated circuit (ASIC) to record biosignals and for stimulation..
    © Fraunhofer IBMT.

    Implants can actively support the body, as in the case of pacemakers, neuroprostheses or cochlear implants. In the future, active implants will be smaller, less energy-intensive and, above all, more patient-friendly. This is why the Fraunhofer Institute for Biomedical Engineering IBMT is working on miniaturization, external power supplies and wirelessly networked implants. The latest developments will be presented at COMPAMED/MEDICA in Düsseldorf from November 15 to 18 (Hall 13, Stand D60).

    more info